Related Experiment Video
Updated: Aug 10, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular
D S Blondheim1, L E Jacobs, M N Kotler
1Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA.
Insights
Mitral regurgitation (MR) in dilated cardiomyopathy patients is linked to fewer left ventricular thrombi but significantly reduced survival rates. This finding highlights MR as a key indicator of poor prognosis.
Area of Science:
- Cardiology
- Echocardiography
- Cardiovascular Research
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
- Left ventricular thrombi (LVT) are a known complication of DCM, increasing embolic risk.
- Mitral regurgitation (MR) is common in DCM, but its prognostic implications require further elucidation.
Purpose of the Study:
- To investigate the relationship between mitral regurgitation (MR) and left ventricular thrombi (LVT) in patients with dilated cardiomyopathy (DCM).
- To assess the impact of MR on apical flow velocities and survival in DCM patients.
- To determine if MR can serve as a noninvasive marker for prognosis in DCM.
Main Methods:
- Echocardiography (2D, pulsed, and color Doppler) was used in 91 DCM patients.
- Assessment included quantification of MR, measurement of apical flow velocities, and detection of LVT.
- Follow-up data was collected to evaluate patient survival.
Main Results:
- MR was detected in 57% of patients; LVT in 40%.
- The co-occurrence of MR and LVT was infrequent (8%).
- Patients with MR exhibited significantly higher apical flow velocities and markedly decreased survival rates (22% vs. 60% at 32 months).
Conclusions:
- Mitral regurgitation in DCM is associated with reduced left ventricular thrombus formation.
- MR is a sensitive, noninvasive marker indicating significantly decreased survival in dilated cardiomyopathy.
- Even mild MR portends a worse prognosis in DCM patients.
Abstract:
Ninety-one patients with dilated cardiomyopathy were studied by two-dimensional, pulsed, and color Doppler echocardiography (1) to detect and quantify mitral regurgitation (MR), (2) to record apical flow velocities in systole and diastole, and (3) to detect the presence of left ventricular thrombi. MR was detected in 57% of the patients and thrombi were present in 40%, but the occurrence of both MR and thrombus was rare (8%). Apical flow velocity was significantly higher throughout the cardiac cycle in the group with MR (diastole 15 +/- 7 vs 9 +/- 7 cm/sec; systole 29 +/- 12 vs 16 +/- 13 cm/sec; p less than 0.001 for both), accounting for the rarity of thrombi in this group. Follow-up data on 89% of the patients showed markedly decreased survival in the group with MR (22% vs 60% at 32 +/- 6 months, p less than 0.005), and this was evident even in patients with mild MR. Thus although MR is a noninvasively obtainable marker of a large subgroup of patients with dilated cardiomyopathy "protected" from left ventricular thrombus formation, it is a sensitive marker of decreased survival.
More Related Videos
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management

